A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

Clinical trial NCT05897320 · RECRUITING

Trial details

NCT number: NCT05897320
Sponsor: H. Lundbeck A/S
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Episodic Migraine

Start date: 2023-06-08
Primary completion: 2027-07-06
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.